Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy

European Journal of Heart Failure

Volumn 6, Issue 6, 2004, Pages 735-743

  Patrianakos, Alexander P ^a   Parthenakis, Frangiskos I ^a   Papadimitriou, Evangelos A ^a   Diakakis, George F ^a   Tzerakis, Panagiotis G ^a   Nikitovic, Dragana ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cardiopulmonary exercise; Cytokines; Diastolic function; EF, ejection fraction; HF, heart failure; LV, left ventricle; Natriuretic peptides; NIDC, non ischemic dilated cardiomyopathy; Non ischemic dilated cardiomyopathy; RFP, restrictive filling pattern

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CONGESTIVE CARDIOMYOPATHY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HUMAN; PRIORITY JOURNAL;

AGED; CARDIOMYOPATHY, DILATED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7944238515     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.11.013     Document Type: Article

References (41)

1. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241
2. Torre-Amione G., Kapadia S., Benedict C.R., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206
3. Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertensionm. J Am Coll Cardiol. 28:1996;964-971
4. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive failure. Circulation. 92:1995;1479-1486
5. Wei C.M., Heublein D.M., Perella M.A., et al. Natriuretic peptide system in human heart failure. Circulation. 88:1993;1004-1009
6. Lerman A., Gibbons R.J., Rodeheffer R.J., et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptom-less left-ventricular dysfunction. Lancet. 341:1993;1105-1109
7. Davidson N.C., Naas A.A., Hanson J.K., et al. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol. 77:1996;828-831
8. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516
9. Pinamonti B., DiLenarda A., Sinagra G.F., et al. (The Heart Muscle Disease Study Group). Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 22:1993;808-815
10. Xie G.Y., Berk M.R., Smith M.D., et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 24:1994;1041-1045
11. Pardaens K., Van Cleemput J., Vanhaecke J., Fagard R.H. Peak oxygen uptake better predicts outcome than sub maximal respiratory data in heart transplant candidates. Circulation. 101:2000;1152-1157
12. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786
13. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc, 2000; 284:3043-3045
14. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiog. 2:1989;358-367
15. Helmcke F., Nanda N.C., Hsiung M.C., et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 75:1987;175-183
16. Dumesnil J.G., Gaudreault G., Honos G.N., Kingma J.G. Jr. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol. 68:1991;515-519
17. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., De Maria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 24:1994;132-139
18. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 310:2001;193-197
19. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86:2001;21-26
20. McCullough P., Omland T., Maisel A. B-Type natriuretic peptides:a diagnostic breakthrough for clinicians. Rev Cardiovasc Med. 4:(2):2003;72-80
21. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704
22. Francis S., Holden H., Holt C., Duff G. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol. 30:1998;215-223
23. Kapadia S., Yakoob K., Nader S., Thomas J., Mann D., Griffin B.P. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. JACC. 36:(1):2000;208-212
24. Kan H., Finkel M.S. Interactions between cytokines and neurohormonal systems in the failing heart. Heart Fail Rev. 6:2001;119-127
25. Nagueh S.F, Estimation of left ventricular filling pressures by Doppler echocardiography, ACC Current Journal Review, 11 1: 41-45
26. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., Mann D.L. Hemodynamic regulation of tumor necrosis factor-a gene and protein expression in adult feline myocardium. Circ Res. 81:(2):1997;187-195
27. Li J., Hampton T., Morgan J.P., Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 100:1997;18-24
28. Baumgarten G., Knuefermann P., Kalra D., et al. Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation. 105:2002;2192-2197
29. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effect of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389
30. 2+] and cell contraction in cultured-chick ventricular myocytes. Circ Res. 75:1994;285-295
31. Deswal A., Petersen N., Feldman A., Young J., White B., Mann D.L. Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST). Circulation. 103:2001;2055-2059
32. Solomon K.A., Pesti N., Wu G., et al. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol. 163:1999;4105-4108
33. Satoh M., Nakamura M., Saitoh H., et al. Tumor necrosis factor-a converting enzyme and tumor necrosis factor-a in human dilated cardiomyopathy. Circulation. 99:1999;3260-3265
34. Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 132:1993;1961-1970
35. Yu C.M., Sanderson J.E., Shum I.O., et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the RFP. Eur Heart J. 17:(11):1996 November;1694-1702
36. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13
37. Lubien E., DeMaria A., Krishnaswamy P., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with doppler velocity recordings. Circulation. 105:2002;595-601
38. Parthenakis F.I., Kanoupakis E.M., Kochiadakis G.E., et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J. 140:(2):2000 August;338-344
39. Tabet J.Y., Logeart D., Geyer C., et al. Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur Heart J. 21:(22):2000 November;1864-1871
40. Anker S.D., Volterrani M., Egerer K.R., et al. Tumour necrosis factor alpha as a predictor of impaired peak le.g. Blood flow in patients with chronic heart failure. Q J Med. 91:1998;199-203
41. Kruger S., Graf J., Kunz D., et al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 40:(4):2002 August 21;718-722